MELISSA PRASATIK: Open Payments
NPI 1467670794 · KIRKLAND, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$387 in 21 payments from 10 companies in 2025. Trend: 2023 $326 · 2024 $328 · 2025 $387
Food & beverage: $387
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 4 | $77 |
| Novartis Pharmaceuticals Corporation | 2 | $69 |
| GENZYME CORPORATION | 3 | $56 |
| ABBVIE INC. | 2 | $42 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $36 |
| Almirall LLC | 2 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Incyte Corporation | 1 | $21 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $16 |
| Galderma Laboratories, L.P. | 1 | $16 |
Products named: DUPIXENT, ADBRY, Rhapsido, SKYRIZI, OPZELURA, RINVOQ, NEMLUVIO, Seysara.
Industry payments across WA — which companies pay providers there.
